SOM Share Price Performance
AU$0.77
0.33 (73.86%)
23.2% undervalued intrinsic discount
AU$1.00
Fair Value
Price AU$0.77
AnalystConsensusTarget AU$1.00
Fair ValueAU$1.00
Share Pricen/a
SomnoMed Limited Stock Price
- 1 Narratives written by author
- 0 Comments on narratives written by author
- 5 Fair Values set on narratives written by author
SOM Community Narratives
AN
Fair Value AU$1 23.2% undervalued intrinsic discount
Global Shift Toward Less Intrusive Sleep Apnea Therapies Will Drive Long-Term Device Demand
0users have liked this narrative
0users have commented on this narrative
1users have followed this narrative
Global Shift Toward Less Intrusive Sleep Apnea Therapies Will Drive Long-Term Device Demand
Catalysts About SomnoMed SomnoMed develops and manufactures oral appliance therapies and connected solutions for treating obstructive sleep apnea globally. What are the underlying business or industry changes driving this perspective?Read more
10
users have viewed this narrative0users have liked this narrative
0users have commented on this narrative
1users have followed this narrative
AN
AU$1
23.2% undervalued intrinsic discount
AnalystConsensusTarget's Fair Value
Revenue
9.09% p.a.
Profit Margin
0.046%
Future PE
39.84x
Price in 2028
AU$0.01
Trending Discussion
Recently Updated Narratives
AN
Global Shift Toward Less Intrusive Sleep Apnea Therapies Will Drive Long-Term Device Demand
Fair Value: AU$1 23.2% undervalued intrinsic discount
1 followerusers have followed this narrative
0 commentsusers have commented on this narrative
0 likesusers have liked this narrative
Snowflake Analysis
SomnoMed Limited Key Details
Last Reported Earnings
Jun 30, 2025
Next Reporting Earnings
n/a
- -0.016
- 59.85%
- -3.10%
- 1.7%
About SOM
- Founded
- 1987
- Employees
- n/a
- CEO
- WebsiteView website
SomnoMed Limited, together with its subsidiaries, produce and sells devices for the oral treatment of sleep related disorders in the Asia Pacific region, North America, and Europe. It provides SomnoDent Avant, as well as SomnoDent Classic, SomnoDent Flex, and SomnoDent Fusion are offered for the treatment of obstructive sleep apnea. The company also offers SomMorning Repositioner, a product designed to help return patient’s mandible back to its pre-treatment centric position; SomnoBrux splint, a custom fit, acrylic splint for patient’s upper teeth designed to protect teeth from grinding and scraping during Bruxism; and SomTabs, which are cleaning tablets to clean oral appliances. SomnoMed Limited was incorporated in 1987 and is headquartered in Crows Nest, Australia.
